Results 141 to 150 of about 20,750 (203)

Dabrafenib plus trametinib in an elderly patient with BRAF V600E-mutant advanced pancreatic adenocarcinoma: A case report. [PDF]

Front Oncol
Liu L, Zhu X, Guo Y, Tang M, Zhou W, Chen B.   +5 more
europepmc   +1 more source

From MAiD Referral to Targeted Therapy Success: A Case of <i>BRAF</i>-Mutated Anaplastic Thyroid Cancer. [PDF]

Reports (MDPI)
Stubbert B, Stewart P, Winquist E, Cecchini M, Browne C.   +4 more
europepmc   +1 more source

Delayed Neurologic Response to Dabrafenib and Trametinib in the Case of Mixed Histiocytosis (LCH/ECD): Case Report and Literature Review. [PDF]

Reports (MDPI)
Imashuku S, Kobayashi M, Miyoshi T, Anzai N.   +3 more
europepmc   +1 more source

BRAF inhibitor or BRAF/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer. [PDF]

Arch Endocrinol Metab
Finkel I, Korzets Y, Moore A, Coreanu T, Popovtzer A, Shoffel-Havakuk H, Bachar G, Mansour J, Weiss C, Robenshtok E.   +9 more
europepmc   +1 more source

RAF inhibitors activate the integrated stress response by direct activation of GCN2. [PDF]

Nat Commun
Gilley R, Kidger AM, Neill G, Morrison E, Severson P, Byrne DP, Kenneth NS, Bollag G, Zhang C, Maia de Oliveira T, Eyers PA, Bayliss R, Masson GR, Cook SJ.   +13 more
europepmc   +1 more source

A case report of neoadjuvant targeted therapy in stage IIIA non-small cell lung cancer with <i>BRAF V600E</i> mutation. [PDF]

Front Med (Lausanne)
Peng W, Qu S, Cai L, Yang R, Dong M, Li X, Ran F, Luo C.   +7 more
europepmc   +1 more source

Efficacy and safety of dabrafenib-targeted therapy for pediatric langerhans cell histiocytosis: a systematic review and meta-analysis. [PDF]

Transl Pediatr
Lu Y, Ye Y, Ren W, Leng X, Dai Y.
europepmc   +1 more source

An Adult Case of Chest Wall Langerhans Cell Histiocytosis Mimicking Malignancy and Responding to Targeted Therapy. [PDF]

Cureus
Alchaer MW, Capelli T, Abbruzzese TA, Wright A.   +3 more
europepmc   +1 more source

Multifunctional Cu-DEOD porous polymeric nanocomposite for broad-spectrum biomedical applications. [PDF]

RSC Adv
Alotaibi HF, Sead FF, Altalbawy FMA, Yousif N, Sahib AS, Abdulali ZS, Alwan M, Jasem M, Mushtaq H, Faye A, Smerat A.   +10 more
europepmc   +1 more source

Identification of MFSD3 as a potential prognostic biomarker of cervical cancer. [PDF]

Discov Oncol
Guo L, Zhang Q.
europepmc   +1 more source